Notably, rapamycin leads to a decreased ATF3 expression level, which is probably a negative feedback regulatory mechanism of HCC cells to maintain necessary lipid synthesis under the stress of rapamycin (Figure 4L). Here, ATF3 is linked to hepatocellular carcinoma.